z-logo
open-access-imgOpen Access
Acalabrutinib & Rituximab Treatment for Previously Untreated CLL/SLL
Author(s) -
Catlin Nalley
Publication year - 2022
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000822052.81506.b0
Subject(s) - medicine , rituximab , oncology , hematology , chronic lymphocytic leukemia , leukemia , lymphoma

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here